Utah Medical Products Stock Today
| UTMD Stock | USD 65.15 0.02 0.03% |
Performance0 of 100
| Odds Of DistressLess than 5
|
Utah Medical is trading at 65.15 as of the 28th of November 2024, a 0.03 percent decrease since the beginning of the trading day. The stock's lowest day price was 65.15. Utah Medical has under 5 % chance of experiencing financial distress over the next 2 years, but has generated negative returns over the last 90 days. Equity ratings for Utah Medical Products are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 8th of March 1999 | Category Healthcare | Classification Health Care |
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company was incorporated in 1978 and is headquartered in Midvale, Utah. Utah Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. The company has 3.39 M outstanding shares of which 56.8 K shares are at this time shorted by private and institutional investors with about 2.62 trading days to cover. More on Utah Medical Products
Moving against Utah Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Utah Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman | Kevin Cornwell | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsUtah Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Utah Medical's financial leverage. It provides some insight into what part of Utah Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Utah Medical Products (UTMD) is traded on NASDAQ Exchange in USA. It is located in 7043 South 300 West, Midvale, UT, United States, 84047-1048 and employs 169 people. Utah Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 221.03 M. Utah Medical Products conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 3.39 M outstanding shares of which 56.8 K shares are at this time shorted by private and institutional investors with about 2.62 trading days to cover.
Utah Medical Products currently holds about 69.51 M in cash with 22.28 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.17.
Check Utah Medical Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Utah Medical is $221.03 Million. The majority of Utah Medical Products outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Utah Medical to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Utah Medical Products. Please pay attention to any change in the institutional holdings of Utah Medical Products as this could imply that something significant has changed or is about to change at the company. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the company is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Utah Ownership Details
Utah Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 71.7 K | |
| Jpmorgan Chase & Co | 2024-06-30 | 62.8 K | |
| Bank Of New York Mellon Corp | 2024-06-30 | 49.6 K | |
| Minerva Advisors Llc | 2024-09-30 | 42.3 K | |
| Acadian Asset Management Llc | 2024-06-30 | 41.4 K | |
| Millennium Management Llc | 2024-06-30 | 39 K | |
| Northern Trust Corp | 2024-09-30 | 35.1 K | |
| Isthmus Partners Llc | 2024-09-30 | 32.1 K | |
| Los Angeles Capital Management Llc | 2024-09-30 | 30.6 K | |
| Fmr Inc | 2024-09-30 | 268.8 K | |
| Renaissance Technologies Corp | 2024-09-30 | 230.6 K |
Utah Medical Historical Income Statement
Utah Stock Against Markets
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Dividend Share 1.2 | Earnings Share 4.28 | Revenue Per Share 12.392 | Quarterly Revenue Growth (0.20) |
The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.